Ichor Medical Systems has entered into a product development collaboration and worldwide license agreement with Janssen Pharmaceuticals Read the full story

Janssen Pharmaceuticals has acquired XO1 Limited Read the full story

Big pharma giant Johnson & Johnson has found a buyer for its Cordis unit, a manufacturer of cardiology and endovascular devices, which it put on the market in August 2014 . Read the full story

Voyager Therapeutics and Genzyme announced a major strategic collaboration to discover, develop and commercialize novel gene therapies for severe CNS disorders Read the full story

Depomed has entered into a definitive agreement to acquire the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals for $1.05 billion Read the full story

AC Immune has entered into a worldwide exclusive license agreement and research collaboration with Janssen Pharmaceuticals Read the full story

Vectura has entered into a global development and licence agreement with Janssen Biotech for the exclusive development of novel anti-inflammatory therapies for the treatment of asthma/COPD Read the full story

Isis Pharmaceuticals has entered into a global collaboration with Janssen Biotech to discover and develop antisense drugs to treat autoimmune disorders of the gastrointestinal (GI) tract Read the full story